4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000033
Sr. VP & Chief Medical Officer sold 4,155 shares at an average $92.32 ($383,596)
- Sr. VP & Chief Medical Officer acquired 2,955 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adda Nathalie · Sr. VP & Chief Medical Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-08-20 | Exercise or conversion : show line 1 in the form | +2,955 | $43.46 | $128,424 | 4,465 | D |
| 2018-08-20 | Sale : show line 2 in the form | −572 | $90.58 | $51,812 | 3,893 | D |
| 2018-08-20 | Sale : show line 3 in the form | −700 | $91.49 | $64,042 | 3,193 | D |
| 2018-08-20 | Sale : show line 4 in the form | −2,224 | $92.68 | $206,130 | 969 | D |
| 2018-08-20 | Sale : show line 5 in the form | −659 | $93.49 | $61,613 | 310 | D |
| Open-market sales · 4,155 sh · avg $92.32 · $383,596 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-08-20 | Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) | −2,955 | $43.46 | 2025-06-29 | 2,955 | 75,225 | D |
Loading xslF345X03/edgar.xml…